diazinon has been researched along with Disease Models, Animal in 9 studies
Diazinon: A cholinesterase inhibitor that is used as an organothiophosphorus insecticide.
diazinon : A member of the class of pyrimidines that is pyrimidine carrying an isopropyl group at position 2, a methyl group at position 6 and a (diethoxyphosphorothioyl)oxy group at position 4.
Disease Models, Animal: Naturally-occurring or experimentally-induced animal diseases with pathological processes analogous to human diseases.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Three groups of eight dogs each were studied to evaluate the early evolution of the hyperamylasemia, hyperlipasemia, and acinar cell pathology at the light and electron microscopic levels during acute Diazinon-induced pancreatitis." | 7.66 | The effect of atropine and duct decompression on the evolution of Diazinon-induced acute canine pancreatitis. ( Borner, JW; Dressel, TD; Goodale, RL; Zweber, B, 1982) |
| "Three groups of eight dogs each were studied to evaluate the early evolution of the hyperamylasemia, hyperlipasemia, and acinar cell pathology at the light and electron microscopic levels during acute Diazinon-induced pancreatitis." | 3.66 | The effect of atropine and duct decompression on the evolution of Diazinon-induced acute canine pancreatitis. ( Borner, JW; Dressel, TD; Goodale, RL; Zweber, B, 1982) |
| "Diazinon (DZN) is an organophosphate pesticide widely used in agricultural to control insects and in veterinary medicine to control ectoparasites." | 1.38 | The role of oxidative stress in diazinon-induced tissues toxicity in Wistar and Norway rats. ( Abasnezhad, M; Ahmadi, S; Asgari, A; Hajigholamali, M; Jafari, M; Salehi, M, 2012) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (11.11) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (33.33) | 29.6817 |
| 2010's | 4 (44.44) | 24.3611 |
| 2020's | 1 (11.11) | 2.80 |
| Authors | Studies |
|---|---|
| Abrams, RPM | 1 |
| Yasgar, A | 1 |
| Teramoto, T | 1 |
| Lee, MH | 1 |
| Dorjsuren, D | 1 |
| Eastman, RT | 1 |
| Malik, N | 1 |
| Zakharov, AV | 1 |
| Li, W | 1 |
| Bachani, M | 1 |
| Brimacombe, K | 1 |
| Steiner, JP | 1 |
| Hall, MD | 1 |
| Balasubramanian, A | 1 |
| Jadhav, A | 1 |
| Padmanabhan, R | 1 |
| Simeonov, A | 1 |
| Nath, A | 1 |
| Yousefizadeh, S | 1 |
| Farkhondeh, T | 1 |
| Samarghandian, S | 1 |
| Razavi, BM | 1 |
| Hosseinzadeh, H | 1 |
| Movassaghi, AR | 1 |
| Imenshahidi, M | 1 |
| Abnous, K | 1 |
| Savy, CY | 1 |
| Fitchett, AE | 1 |
| McQuade, R | 1 |
| Gartside, SE | 1 |
| Morris, CM | 1 |
| Blain, PG | 1 |
| Judge, SJ | 1 |
| Jafari, M | 1 |
| Salehi, M | 1 |
| Ahmadi, S | 1 |
| Asgari, A | 1 |
| Abasnezhad, M | 1 |
| Hajigholamali, M | 1 |
| Cho, JH | 1 |
| Jeong, SH | 1 |
| Yun, HI | 1 |
| Roegge, CS | 1 |
| Timofeeva, OA | 1 |
| Seidler, FJ | 2 |
| Slotkin, TA | 2 |
| Levin, ED | 2 |
| Ryde, IT | 1 |
| Dressel, TD | 1 |
| Goodale, RL | 1 |
| Zweber, B | 1 |
| Borner, JW | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Protection of Cardiovascular Function With Crocin in BrEast Cancer Patients Undergoing Radiotherapy and Chemotherapy[NCT05504148] | 120 participants (Anticipated) | Interventional | 2021-03-29 | Recruiting | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
9 other studies available for diazinon and Disease Models, Animal
| Article | Year |
|---|---|
Therapeutic candidates for the Zika virus identified by a high-throughput screen for Zika protease inhibitors.
Topics: Animals; Antiviral Agents; Artificial Intelligence; Chlorocebus aethiops; Disease Models, Animal; Dr | 2020 |
Age-Related Diazinon Toxicity Impact on Blood Glucose, Lipid Profile and Selected Biochemical Indices in Male Rats.
Topics: Administration, Oral; Age Factors; Aging; Animals; Blood Glucose; Cholesterol, LDL; Diazinon; Diseas | 2019 |
Protective effect of crocin on diazinon induced cardiotoxicity in rats in subchronic exposure.
Topics: Animals; Antioxidants; Apoptosis; bcl-2-Associated X Protein; Carotenoids; Creatine Kinase; Crocus; | 2013 |
Low-level repeated exposure to diazinon and chlorpyrifos decrease anxiety-like behaviour in adult male rats as assessed by marble burying behaviour.
Topics: Acetylcholinesterase; Analysis of Variance; Animals; Anti-Anxiety Agents; Anxiety; Brain; Chlorpyrif | 2015 |
The role of oxidative stress in diazinon-induced tissues toxicity in Wistar and Norway rats.
Topics: Animals; Brain; Cell Survival; Cholinesterases; Diazinon; Disease Models, Animal; Dose-Response Rela | 2012 |
Changes of urinary and blood porphyrin profiles by exposure to PCBs, lead or diazinon in rats.
Topics: Administration, Oral; Animals; Cattle; Diazinon; Disease Models, Animal; Dose-Response Relationship, | 2003 |
Developmental diazinon neurotoxicity in rats: later effects on emotional response.
Topics: Age Factors; Analysis of Variance; Animals; Animals, Newborn; Behavior, Animal; Cholinesterase Inhib | 2008 |
Developmental neurotoxicity of low dose diazinon exposure of neonatal rats: effects on serotonin systems in adolescence and adulthood.
Topics: Age Factors; Analysis of Variance; Animals; Animals, Newborn; Brain; Cholinesterase Inhibitors; Diaz | 2008 |
The effect of atropine and duct decompression on the evolution of Diazinon-induced acute canine pancreatitis.
Topics: Acute Disease; Amylases; Animals; Atropine; Cholinesterases; Diazinon; Disease Models, Animal; Dogs; | 1982 |